Neurocrine Biosciences Inc at Bank of America Merrill Lynch Napa Healthcare Conference (Virtual) Transcript
Okay. I'm not sure if I'm supposed to read any kind of disclosures, but I'm going to go ahead and introduce myself. I'm Tazeen Ahmad. I'm one of the med biotech analysts here at Bank of America. It's my pleasure this afternoon to introduce our next presenting company, Neurocrine. Speaking for Neurocrine this afternoon is CEO, Kevin Gorman; and Kyle Gano, who is Chief Business Development and Strategy Officer.
Kevin and Kyle, good afternoon. Thanks for joining us.
Good afternoon, Tazeen. Thanks for having us.
Questions & Answers
So I think everyone that's joined us on this particular call is pretty familiar with Neurocrine already. So, Kevin, I won't ask you to do the 2-minute elevator pitch that we follow on this webcast. But I did want to get a sense, an update, if you will, on where you guys are currently as it
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |